Segment Reporting

6 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Reporting

(12) SEGMENT REPORTING

At June 30, 2014, the Company has determined that it has one reporting segment, the Electrotherapy and Pain Management segment, which includes the ZMI TENS units and compound pain creams that accounted for 92% of  total net revenue for the six months ended June 30, 2014. The determination was made based on the fact that the products are marketed through the same sales representatives and to the same medical providers whether the provider writes a prescription for a TENS device or compound pain cream. As discussed in Note 1, during the quarter ended June 30, 2014, the Company has narrowed its focus to these products. The revenue generated from the sale of other products and services is not significant.

Net revenue was primarily generated from sales in the United States.